Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Mar 09 2022
Business
Mar 9 2022
3 min read

Press Release Mar 09 2022

Cadila Healthcare Limited has informed the Exchange about press release dated 09-Mar-2022 titled ���Zydus receives final approval from USFDA for Nitroglycerin Sublingual Tablets���.

View Attachment